REPH - Recro Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Recro Pharma's activity chart (see below) currently has 23 price targets and 20 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.82% with an average time for these price targets to be met of 175.82 days.

Most recent stock forecast was given by from CRAIG HALLUM on 04-Jan-2021. First documented stock forecast 16-Sep-2016.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Oct-2019

$5

$4.21 (532.91%)

$18

Buy Since 12-May-2020

$12

$11.21 (1418.99%)

$18

Show more analysts

Please expand the browser size to see the chart

What is REPH (Recro Pharma) average time for price targets to be met?

On average it took 175.82 days on average for the stock forecasts to be realized with a an average price target met ratio 51.82

Which analyst has the current highest performing score on REPH (Recro Pharma) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on REPH (Recro Pharma)?

Scott Henry works at ALLIANCE GLOBAL PARTNERS and has 7 price targets and 4 ratings on REPH

Which analyst is the currently most bullish on REPH (Recro Pharma)?

Leland Gershell with highest potential upside - $11.21

Which analyst is the currently most reserved on REPH (Recro Pharma)?

David Amsellem with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?